OpenVSafe by OpenVAERS
Search V-safe

RQ4-27808-66544

3 vaccinations 1 coded response 5 check-ins 0 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
967 / HI
Registered
2022-02-28
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-28
    Dose 1 — Moderna
  2. 2021-02-25
    Dose 2 — Moderna
  3. 2022-02-28
    Registered in v-safe
  4. 2022-02-28
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  5. 2022-03-02
    Dose 3 — Pfizer-BioNTech
  6. 2022-04-18
    Health check-in — day 42, dose 3
    Feeling: Fair
    Adult check-in
  7. 2022-06-04
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  8. 2022-08-31
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  9. 2023-03-02
    Survey response — 12 months, dose 3
    MedDRA: Psoriasis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  10. 2023-03-02
    Report sent to call center — 12 months, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  11. 2023-03-03

Vaccinations

DoseDateManufacturerCo-administered
12021-01-28Moderna No
22021-02-25Moderna No
32022-03-02Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDPsoriasis · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release